Cart
sales@molnova.com
N6-Cyclopentyladenosine
CAS No. 41552-82-3
N6-Cyclopentyladenosine( —— )
Catalog No. M33438 CAS No. 41552-82-3
N6-Cyclopentyladenosine (CPA) is a selective agonist of the adenosine A1 receptor, mimicking its action with Ki values of 2.3 nM, 790 nM, and 43 nM for human A1, A2A, and A3 receptors, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | In Stock |
|
| 10MG | 43 | In Stock |
|
| 25MG | 61 | In Stock |
|
| 50MG | 82 | In Stock |
|
| 100MG | 147 | In Stock |
|
| 500MG | 357 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN6-Cyclopentyladenosine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN6-Cyclopentyladenosine (CPA) is a selective agonist of the adenosine A1 receptor, mimicking its action with Ki values of 2.3 nM, 790 nM, and 43 nM for human A1, A2A, and A3 receptors, respectively.
-
DescriptionN6-Cyclopentyladenosine (CPA) is a selective Adenosine A1 receptor agonist, with Ki values of 2.3 nM, 790 nM and 43 nM for human A1, A2A and A3 receptors, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAdenosine Receptor
-
RecptorAdenosine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number41552-82-3
-
Formula Weight335.36
-
Molecular FormulaC15H21N5O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 12.5 mg/mL (37.27 mM; Ultrasonic ) H2O : 2.5 mg/mL (7.45 mM; Ultrasonic (<60°C)
-
SMILESOC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NC3CCCC3)ncnc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Klotz KN, et al. Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):382-91.?
molnova catalog
related products
-
CGS 21680
CGS 21680 is a specific adenosine A2A subtype receptor agonist with Ki of 27 nM.
-
LAS38096
LAS38096 is an A2B adenosine receptor antagonist (Ki : 17 nM) that is potent, selective and efficient .
-
Evodenoson
Evodenoson (ATL313) is a potent and selective adenosine A2a receptor (A2aR) agonist for the treatment of eye diseases, tumors, and immune system disorders, and may be used in studies of open-angle glaucoma and blood tumors.
